Article info

Download PDFPDF

The prognostic value of excission repair cross-complementation group one enzyme expression in locally advanced cervical carcinoma patients treated with cisplatin–based treatment: a meta–analysis

Authors

  1. Correspondence to Ke Gu, Department of Radiation Oncology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou 215001, China; drguke{at}163.com
View Full Text

Citation

Zhu J, Ji S, Hu Q, et al
The prognostic value of excission repair cross-complementation group one enzyme expression in locally advanced cervical carcinoma patients treated with cisplatin–based treatment: a meta–analysis

Publication history

  • Received July 11, 2018
  • Revision received August 7, 2018
  • Accepted September 6, 2018
  • First published January 7, 2019.
Online issue publication 
January 07, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.